Siplizumab

( DrugBank: Siplizumab / KEGG DRUG: Siplizumab )


2 diseases
IDDisease name (Link within this page)Number of trials
94Primary sclerosing cholangitis1
IDDisease name (Link within this page)Number of trials
95Autoimmune hepatitis1

94. Primary sclerosing cholangitis


Clinical trials : 177Drugs : 120 - (DrugBank : 48) / Drug target genes : 25 - Drug target pathways : 148 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

95. Autoimmune hepatitis


Clinical trials : 58Drugs : 56 - (DrugBank : 27) / Drug target genes : 23 - Drug target pathways : 114 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries